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Abstract 
The photoreactivity of diastereomeric dyads containing (S)- or (R)-flurbiprofen (FBP) and (S)-
Tyr, either directly linked (1) or separated by a cyclic spacer (3) has been investigated. The 
main feature is a remarkable intramolecular quenching of FBP fluorescence, especially in 1. The 
process is clearly configuration dependent, being more efficient for the (R,S)- diastereomer in 1 
and for the (S,S)- analogue in 3. Noteworthy, exciplex emission is detected in the 380-500 nm 
region in the case of 3. Fluorescence decay kinetics from the femtosecond to the nanosecond 
time-domains provides evidence for the dynamic nature of the quenching. In agreement with the 
steady-state and time-resolved observations, molecular modelling points to a more favourable 
geometric arrangement of the two interacting chromophores in 1 than in 3.  
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The binding of drugs to proteins constitutes an active research field in connection with drug 
transport and distribution through the organism, which is ultimately related to the therapeutic 
action. The interactions existing between drugs and proteins can modulate properties of the 
former, such as solubility in plasma, susceptibility to some reagents or in vivo half-life [1-4]. In 
this context, a better knowledge on the drug/protein complexation process can shed light on the 
structural bases leading to the design of new therapeutic agents [5, 6].  
Transport proteins, such as serum albumins, are in charge of the binding and transport of 
endogenous and exogenous target molecules through the blood stream [7]. Human serum 
albumin (HSA) contains 585 amino acid residues, one Trp, 17 disulfide bridges, and one free 
Cys [8, 9]. Small organic molecules usually bind to HSA in the so-called site I and site II, 
following Sudlow’s classification [10]; the only Trp residue is located in site I, while site II is 
mainly made-up of Tyr, His and Arg [7]. The role played by different amino acids when drugs 
are incorporated within the protein cavities has been widely investigated, especially for Tyr and 
Trp, which have become universal fluorescent markers for protein studies[11-15]. In addition, it 
is known that chemical modifications on these amino acids result in a decrease of drugs affinity 
for the protein [16, 17].
 
For instance, the presence of a Tyr residue influences the esterase 
activity of bovine serum albumin (BSA) [18].  
Flurbiprofen (FBP, Scheme 1) is a nonsteroidal anti-inflammatory drug (NSAID) prescribed for 
treatment of osteoarthritis, rheumatoid arthritis, tendinitis, bursitis, sunburns and prevention of 
migraine headache [19-24]. Although it is prescribed as a racemic mixture, its pharmacological 
effect is attributed to the (S)- enantiomer [25, 26]. Its photobehaviour has been characterised 
either in aqueous or organic media [27], and binding to HSA has been investigated by 
spectroscopic techniques, namely fluorescence and laser flash photolysis [28-31]. Upon FBP 




Trp* is observed, due to energy 
and electron transfer processes [29]. Concerning 
3
FBP*, the triplet lifetime (T) lengthens within 
the protein cavities, as a result of the protection provided by the microenvironment that prevents 
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from attack by oxygen [28, 30, 31]. Enantioselectivity has been observed in the photobehaviour 
of (R)- and (S)-FBP/HSA complexes [29, 30, 32]. 
The use of dyads that contain a drug covalently linked to an amino acid is a useful tool to mimic 
processes that occur in the protein binding sites of the real supramolecular complexes. In this 
context, light-induced events such as energy transfer, electron transfer, or exciplex formation on 
drug-amino acid dyads have provided the key to demonstrate the mechanistic pathways 
responsible for photoallergy or to estimate the preferred binging site in HSA[29, 33-37].  
We have recently reported a thorough photophysical study on FBP/HSA mixtures, comparing 
their photobehaviour with that of FBP-Trp dyads [29]; stereoselective dynamic fluorescence 
quenching has been noticed in the model systems, although the kinetics of the involved 
processes are slower than in the real drug/protein complexes. Interestingly, an inversed 
stereodifferentiation has been noticed in the dyads with respect to that found for FBP@HSA 
complexes; this can be explained because the relative conformations of the FBP and Trp 
moieties are not necessarily the same in the dyads and within the protein.  
In order to improve the picture on FBP/HSA interactions in the excited states, here we describe 
the photobehaviour of a series of diastereomeric dyads composed of FBP and Tyr, a fluorescent 
close-lying amino acid that may also influence the binding process. The design envisages the 
two subunits either directly linked or separated by means of a rigid spacer (Scheme 1). A 
comparative study on the different dyads would provide useful information on how the distance 












Scheme 1. Chemical structures of the investigated systems. 
2. Experimental section 
2.1. Materials and methods 
(S)- and (R)-Flurbiprofen, (S)-tyrosine methyl ester hydrochloride (TyrMe), (1S,3R)-3-amino-
cyclopentanecarboxylic acid, 1-hydroxybenzotriazole (BtOH), N,N′-dicyclohexylcarbodiimide 
(DCC), N-hydroxysuccinimide (NHS) and 1-(3-dimethylaminopropyl)-N-ethylcarbodiimide 
hydrochloride (EDC) were purchased from Sigma-Aldrich. Their purity was checked by 
1
H 
NMR and HPLC analysis. Spectrophotometric HPLC or reagent grade solvents were obtained 




C-NMR spectra were 
recorded in CDCl3 at 400 and 100 MHz, respectively, using a Bruker AVANCE III instrument; 
chemical shifts are reported in ppm. Steady state absorption spectra were recorded in a JASCO 
V-630 spectrophotometer. The X-ray structure was determined at Unidade de Raios X, at the 
Universidade de Santiago de Compostela. Crystallographic data (excluding structure factors) for 
the (R,S)-1 structure have been deposited at the Cambridge Crystallographic Data Centre as 
supplementary publication number CCDC 662961. 
Exact mass values were obtained using an Ultra Performance Liquid Chromatography (UPLC) 
ACQUITY UPLC system (Waters Corp.) with a conditioned autosampler at 4 °C. The 
separation was accomplished on an ACQUITY UPLC BEH C18 column (50 mm × 2.1 mm i.d., 
1.7 μm), which was maintained at 40 °C. The analysis was performed using acetonitrile and 
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water (80:20 v/v containing 0.01% formic acid) as the mobile phase with a flow rate of 0.5 
mL/min and an injection volume of 5μL. The Waters ACQUITY™ XevoQToF Spectrometer 
(Waters Corp.) was connected to the UPLC system via an electrospray ionization interface. This 
source was operated in positive ionization mode at 100 °C with the capillary voltage at 1.5 kV 
and a temperature of desolvation of 300 °C. The cone and desolvation gas flows were 40 and 
800 L/h, respectively. The collision gas flow and collision energy applied were 0.2 mL/min and 
12 V, respectively. All data collected in Centroid mode were acquired using Masslynx™ 
software (Waters Corp.). Leucine-enkephalin was used at a concentration of 500 pg/L as the 
lock mass generating an [M+H]
+
 ion (m/z 556.2771) and fragment at m/z 120.0813 with a flow 
rate of 50 μL/min to ensure accuracy during the MS analysis. 
Steady-state fluorescence spectra were obtained using a JASCO spectrofluorometer system 
provided with a monochromator in the wavelength range 200-900 nm, with an excitation 
wavelength of 267 nm at 22 ºC. Solutions were placed into 10 mm × 10 mm quartz cells. The 
absorbance of the samples at the excitation wavelength was kept below 0.1. Fluorescence 
quantum yields were determined using FBP in MeCN as reference, with F = 0.17 (air) or F = 
0.21 (N2) [27].  
2.2. Equipment 
Time-resolved fluorescence measurements were performed using the fluorescence upconversion 
(FU) and time-correlated single photon counting (TCSPC) techniques. The excitation source 
was the third harmonic (267 nm) of a mode-locked Ti-Sapphire laser, delivering ~120 fs pulses 
whose repetition rate was 76 and 4.75 MHz for FU and TCSPC, respectively (in the latter case 
set by a pulse-picker).  
For the FU measurements, a home-built setup was used. This has been described in detail earlier 
[38, 39]. Briefly, a 1 mm type I BBO sum-frequency crystal was used, providing an 
instrumental response function of about 350 fs (fwhm). We judge that the time resolution of the 
setup is better than 100 fs after deconvolution, depending on the signal-to-noise ratio. The 
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average excitation power used was 40 mW. The power density cannot be measured precisely 
within the excitation volume but we estimate it to 0.2  0.1 GW/cm
2
 for a 40 mW output from 
the tripler unit (assuming a 40 micron diameter of the focused beam). Solutions (about 30 mL) 
were kept flowing through a 0.4 mm quartz cell, which was kept in continuous motion 
perpendicular to the excitation beam in order to minimize thermal effects. 
For the TCSPC experiments, a Becker & Hickl GmbH SP-630 PC card was used [40]. The 
fluorescence from a standard quartz cell was collected and focused onto the entrance slit of a 
small monochromator (Jobin-Yvon HR250) using off-axis parabolic mirrors. In order to cut the 
laser light, a Schott WG 295 filter was placed in front of the slit. Moreover, a Glan-Thompson 
polarizer ensured that only the vertical component of the fluorescence was detected. The 
detector was a microchannel plate (R1564 U Hamamatsu) providing an instrumental response 
function of 60 ps (fwhm). The average laser power (0.1 mW at 4.75 MHz) was measured with a 
Melles Griot broadband powermeter. The irradiated area on the surface of the cell was ca. 0.2 
cm
2
 corresponding to a pulse intensity of 2.4 kW/cm
2
. Solutions were contained in a 10 mm × 
10 mm quartz cell and continuously stirred. Successive recordings with the same sample gave 
identical decays, which were eventually merged to improve the signal-to-noise ratio. Such a 
procedure allowed us to ensure that the measured signals were not altered during the 
measurements due to a possible accumulation of photoproducts. 
The time-resolved experiments were performed either at magic angle or under successive 
parallel (Ipar(t)) and perpendicular (Iperp(t)) excitation/detection conditions. For both FU and 
TCSPC, the polarization of the exciting beam was set to be either vertical or horizontal using a 
zero-order half-wave plate. Since only the vertical component of the emission was detected, in 
FU by the phase matching conditions of the crystal and in TCPSC by placing a Glan-Thomson 
polarizer in front pf the monochromatic, the parallel and perpendicular components are defined 
only by the polarization of the excitation beam. From the measurements of the parallel and 
perpendicular components, the total (magic angle) fluorescence and the fluorescence anisotropy 
were calculated from the formulae: 
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                                  (2) 
The transmission under parallel and perpendicular conditions was found to be identical so the 
correction factor G was put to unity. 
To evaluate the characteristic times involved, instead of treating F(t) and r(t) separately we 
performed a merged nonlinear fitting/deconvolution process using the impulse response model 
functions 
      tftrtipar 21                                                             (1a) 
      tftrtiperp  1                                                             (1b) 
convoluted by the Gaussian instrument response function, I(t)  i(t)  G(t). The model 
functions thus obtained were fitted to the experimentally measured (Ipar) and (Iperp) signals. The 
full width at half maximum (fwhm) value of a Gaussian apparatus function was found to be 
about 375 ± 12 fs fwhm at 330 nm. 
Laser flash photolysis (LFP) experiments were performed with a Q-switched Nd:YAG laser 
(Quantel Brilliant, 266, 4 mJ per pulse, 5 ns fwhm) coupled to a mLFP-111 Luzchem 
miniaturised equipment. This transient absorption spectrometer includes a ceramic xenon light 
source, 125 mm monochromator, Tektronix 9-bit digitizer TDS-3000 series with 300 MHz 
bandwidth, compact photomultiplier and power supply, cell holder and fibre optic connectors, 
fibre optic sensor for laser-sensing pretrigger signal, computer interfaces, and a software 
package developed in the LabVIEW environment from National Instruments. The LFP 
equipment supplies 5 V trigger pulses with programmable frequency and delay. The rise time of 
the detector/digitizer is ~3 ns up to 300 MHz (2.5 GHz sampling). The monitoring beam is 
provided by a ceramic xenon lamp and delivered through fibre optic cables. The laser pulse is 
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probed by a fibre that synchronizes the LFP system with the digitizer operating in the pretrigger 
mode. Transient spectra were recorded employing 10 mm × 10 mm quartz cells with 4 mL 
capacity and were bubbled for 15 min with N2 before acquisition. The concentration of FBP in 
MeCN was 2.5×10
-5
 M. The experiments were carried out at room temperature. 
3. Results and discussion 
Diastereomeric dyads (S,S)- and (R,S)-1 (containing (S)- or (R)-FBP and (S)-TyrMe directly 
linked) and (S,S)- and (R,S)-3 (with the two subunits separated by a rigid spacer) were 
synthesised by conventional methods. The synthesis and chemical characterization of the new 
compounds are shown in detail in the SI. Briefly, for 1, direct coupling of FBP and TyrMe was 
performed in the presence of EDC and BtOH; for compounds 3, the drug was initially reacted to 
the cyclic spacer in the presence of DCC and DMAP, leading to 2; the latter was esterified with 
TyrMe, to afford the final products. We were able to obtain crystals of (R,S)-1, its X-ray 
structure is presented in the supplementary data (Fig. S7 in the SI).  
Due to the poor solubility of the dyads in aqueous media, the experiments were performed in 
acetonitrile. The UV absorption spectra of dyads 1 and 3 were identical to the added spectra of 
the isolated components (FBP+TyrMe or 2+TyrMe, respectively) at the same concentration (see 
Fig. S8 in the SI); this indicates no significant ground-state interaction between the two 
partners. The presence of the cyclic spacer did not affect the photophysical properties of FBP; 
thus, the photobehaviour of the dyads was always compared to that of FBP. 
Steady-state fluorescence spectra of isoabsorptive solutions (A267 = 0.1) of 1, 3 and FBP were 
recorded at exc = 267 nm; at this wavelength, ca. 90% of the photons are absorbed by FBP. The 
emission consisted on the typical FBP band with maximum at 310 nm, in agreement with the 
lower singlet excited state energy of FBP (99 kcal/mol) compared to that of Tyr (100 kcal/mol) 
[27, 41]. Interestingly, quenching of 
1
FBP* was observed for all the dyads, being more efficient 
for 1 than for 3 (compare Fig. 1A and 1B). The process was stereoselective, with stronger 
quenching for (R,S)-1 than for (S,S)-1 (Fig. 1A); the opposite trend was found for 3: here, the 
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(S,S)-diastereomer evidenced higher quenching than its (R,S)- analogue (Fig. 1B). Remarkably, 
a tiny but not negligible emission tail was detected for 3 at longer wavelengths (>350 nm), with 
intensity slightly higher for (S,S)-3. This fluorescence can be assigned to exciplex species [42-
44], which should normally emit at lower energies and was not observed in the case of dyads 1. 
Actually, subtraction of the normalised emission of FBP from that of normalised emission of 
dyads 3 clearly evidenced the fluorescence arising from exciplexes, with max ca. 360 nm (see 






Fig. 1. Fluorescence spectra of A) (S)-FBP (black line), (S,S)-1 (red line) and (R,S)-1 (blue line), 
and B) (S)-FBP (black line), (S,S)-3 (red triangles) and (R,S)-3 (blue circles) after excitation at 
267 nm in deaerated MeCN. The inset shows emission from exciplex states for dyads 3. 
In order to investigate the dynamic behaviour, femtosecond fluorescence upconversion (FU) 
measurements were performed after excitation at 267 nm (Fig. 2). As observed in a previous 
report, a rise of 7.0 ± 0.6 ps was detected for FBP, assigned to a vibrational relaxation in the 
excited state [45]. A similar rise was also detected for 3, although less pronounced than in FBP 
(see Fig. 2B). However, instantaneous 
1
FBP* formation was noticed for (S,S)-1 and (R,S)-1 
(Fig. 2A); this can be caused by a stronger drug/amino acid coupling. After 10 ps, the kinetic 
profile of (R,S)-1 started to decay faster than that of the (S,S)- analogue; this trend was still 










Fig. 2. Normalised FU decays at mon = 310 nm for A) (S)-FBP (black line), (S,S)-1 (red line) 
and (R,S)-1 (blue line), and B) (S)-FBP (black line), (S,S)-3 (red triangles) and (R,S)-3 (blue 
circles) after excitation at 267 nm in MeCN. The insets show a zoom of the decay traces. 
As explained above, the fluorescence anisotropies at 310 nm were calculated from the parallel 
and perpendicular traces of FBP, 1 and 3 recorded by FU (exc = 267 nm) at 310 nm. The 
fluorescence anisotropies are shown in Fig. 3. The fitting curves obtained for the parallel and 
perpendicular decay traces are shown in Fig. S11 in the SI. The anisotropy decays were longer 
for the dyads than for the parent drug. The fluorescence anisotropy of FBP decayed with a 
characteristic time of about 25 ± 1 ps, with a zero time fluorescence anisotropy r0 = 0.34 ± 0.02. 
However, the anisotropy decays of (S,S)-1 and (R,S)-1 were 51 ± 3 ps (r0 = 0.36 ± 0.02) and 54 
± 4 ps (r0 = 0.36 ± 0.02), respectively. Similar results were obtained for (S,S)-3 (50 ± 3 ps; r0 = 
0.36 ± 0.02) and (R,S)-3 (52 ± 4 ps; r0 = 0.33 ± 0.02). The high r0 values for all dyads indicate 
that the emission comes from the directly excited state, with no change in their electronic 
nature. Besides, the longer characteristic times for the dyads compared to monomeric FBP are 
in full agreement with their larger hydrodynamic volumes. The absence of any fast anisotropy 
decay at early times, together with the mono-exponential behaviour of the kinetics, point to the 











Fig. 3. FU anisotropy decays at mon = 310 nm for A) (S)-FBP (black line), (S,S)-1 (red line) and 
(R,S)-1 (blue line), and B) (S)-FBP (black line), (S,S)-3 (red triangles) and (R,S)-3 (blue circles) 
after excitation at 267 nm in aerated MeCN. 
To fully characterize the dynamics of the investigated systems, time-correlated single photon 
counting (TCSPC) measurements in the nanosecond range were performed. The fluorescence of 
the dyads decayed much faster than that of the isolated drug at 310 nm, indicating an efficient 
dynamic quenching of 
1
FBP* (see Fig. 4A). This quenching is clearly stereoselective. 
Interestingly, the decay of (R,S)-1 was faster than that of the (S,S)- analogue; by contrast, the 
opposite trend was observed for 3, in agreement with the steady-state and FU data. The decay of 
FBP followed a monoexponential law, while two lifetime components were necessary to get a 
good fitting in the dyads; this can be assigned to different conformations. For calculation of rate 
constants and quantum yields, the average lifetime <F> was employed in all cases (see Table 
1). 
The quenching rate constants (kQ), determined from the fluorescence lifetimes (<F>) were on 






, with higher values for dyads 1 than for 3. As regards the radiative rate 





results are in agreement with the steady-state measurements.  
In the case of 3, the kinetic profiles at 420 nm (Fig. 4B) decayed much slower than those at 310 




0.01 ns for (S,S)-3 and (R,S)-3, respectively; this can be attributed to the formation of the 
exciplex [29, 46], previously detected in the steady-state measurements. The exciplex lifetimes 
were 3.27 ± 0.01 ns and 3.05 ± 0.01 ns for (S,S)- and (R,S)-3, respectively. Indeed, the 
anisotropy decay traces at 420 nm were found to be zero at all times for both diastereomers (see 
Fig. S12 in the SI), contrary to that recorded at 310nm. This points to a completely different 
nature of the electronically excited state emitting at 420 nm compared to that emitting at 310 
nm. This strengthens our assignment of the long wavelength emission to an exciplex state for 







Fig. 4. Normalised TCSPC decays (exc = 267 nm, MeCN) at A) mon = 310 nm for (S)-FBP 
(black line), (S,S)-1 (red line), (R,S)-1 (blue line), (S,S)-3 (red triangles) and (R,S)-3 (blue 
circles) (fitted curves are shown in dash) or B) mon = 420 nm for (S,S)-3 (red triangles) and 
(R,S)-3 (blue circles). The inset shows the kinetic rise of the traces monitored at 420 nm during 







Table 1. Photophysical parameters for FBP and dyads 1 and 3 in MeCN.
a
 The fluorescence 
lifetimes were measured by TCSPC. 
 FBP (S,S)-1 (R,S)-1 (S,S)-3 (R,S)-3 
F 0.17 0.09 0.04 0.11 0.15 
F> (ns)














 0.51 2.17 0.48 0.24 
Q(dyn)
e  0.46 0.79 0.44 0.28 
T
f 0.71 0.27 0.14 0.22 0.39 
a The absorbance of the samples was 0.1 at exc = 267 nm;
b F> = a11+ a22, mon = 310 nm;
c kF = F/τF;
d kQ = 
(1/τF(dyad) -1/τF(FBP));
 e Q(dyn) = F(dyad)kQ(dyad)/kF(dyad);
f T = T(FBP)A(dyad)/A(FBP). 
It is known that exciplexes exhibit partial charge separation [47], which is consistent with the 
electron donating character of Tyr [11]. In fact, fluorescence quenching could be due to electron 
transfer (ET) or exciplex formation (EXC). Application of the Weller equation allowed us to 
estimate the G values corresponding to the two possible pathways (equations 3 and 4) [41, 48, 
49]: 


















         
 
   (4) 
where EOX and ERED are the redox potentials of the involved chromophores [50], E0-0 is the 
energy of 
1
FBP* (99 kcal mol
-1





 has a constant value of 0.75 eV. After considering all these parameters, both processes 
were found to be exergonic, with GET = -9 kcal mol
-1
 and GEXC = -4 kcal mol
-1
. Indeed, the 
exciplex was directly observed in dyads 3. 
In order to clarify the differences in the stereoselective fluorescence quenching of the dyads, 
and to get more insight into the conformational arrangements of the two chromophores in the 
linked systems, simple molecular modelling (PM3) was performed (Fig. 5). The geometrical 
arrangement of FBP and Tyr was favoured for interaction in (R,S)-1 due to its folded 
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conformation, which also prevails in the solid state (see Fig. S7 in the SI); this matches with its 
higher fluorescence quenching compared to (S,S)-1, whose geometry was more distorted and 
consequently the quenching was lower. Concerning dyads 3, they clearly presented a more 
unfavourable geometry arrangement to interact, which was even more marked for the (R,S)- 
diastereomer; here, the two chromophores are practically in orthogonal arrangement, which is in 








Fig. 5. Geometry optimised (HyperChem Release 8.0.3 for Windows Molecular Model System, 
PM3) structures for all investigated dyads. 
For investigating the excited state dynamics of longer lived transient species, LFP experiments 
were performed upon excitation at 266 nm, in deaerated acetonitrile. The transient absorption 
spectra of FBP, 1 and 3 are shown in Fig. 6. The dyads displayed the same absorption band 
(max = 360 nm) as the isolated drug, which was assigned to 
3
FBP* [27]. The Amax value at 360 
nm was lower for the dyads than for FBP. This can be explained as a result of the intramolecular 
quenching of the precursor 
1
FBP*, and reproduces the observed stereodifferentiation in the 
singlet excited state. Therefore, for dyads 1, the (R,S)-diastereomer displayed the lower Amax, 
while for 3 the same was true for the (S,S)- analogue. With respect to the triplet lifetime values, 






the triplet excited state (see insets in Fig. 6). Indeed, the lack of interactions from the triplet state 
is in agreement with the Weller equations (3 and 4); thus, considering an energy transfer and/or 
exciplex formation process from 
3
FBP* (65 kcal mol
-1
) [27], it is observed that both processes 
would be thermodynamically disfavoured, with GET = +23 kcal mol
-1










Fig. 6. Laser flash photolysis spectra obtained 0.5 s after the laser pulse of A) (S)-FBP (black 
line), (S,S)-1 (red line) and (R,S)-1 (blue line), and B) (S)-FBP (black line), (S,S)-3 (red 
triangles) and (R,S)-3 (blue circles) after excitation at 266 nm in deaerated MeCN. The insets 
show the decay traces at 360 nm. 
4. Conclusions 
The photophysical properties of diastereomeric dyads composed of flurbiprofen linked to 
tyrosine, an amino acid residue that plays a key role in the interactions of drugs to transport 
proteins, have been characterised in detail. The photoreactivity is strongly influenced by the 
distance and conformational arrangement between the two chromophores. Thus, the directly 
linked dyads exhibit a more efficient fluorescence quenching than those separated by the cyclic 
spacer. This stereoselective quenching has been found to be mainly dynamic in nature, as 
observed from the FU and TCSPC experiments. Application of the Weller equation is in 






FBP* quenching. Molecular modelling results are in agreement with the detected 
stereoselectivity. Finally, no significant interactions involving the FBP excited triplet state have 
been noticed; this observation contrasts with the dramatic lengthening of the triplet lifetimes of 
the drug within the protein binding sites, which has to be attributed to the microenvironment 
provided by the tertiary structure of these biomolecules. 
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